Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.22.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
REVENUES $ 1,868 $ 1,546
COST OF REVENUES 1,286 818
GROSS PROFIT 582 728
OPERATING EXPENSES:    
Research and development expenses, net 650 620
Sales and marketing expenses, net 730 411
General and administrative expenses, net 635 322
TOTAL OPERATING EXPENSES 2,015 1,353
OPERATING LOSS (1,433) (625)
Financial expenses, net (3,206) (54)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (4,639) $ (679)
Net loss per share attributable to common shareholders – basic and diluted (in Dollars per share) $ (2.26) $ (0.33)
Weighted average number of common stock used in computing net loss per share – basic and diluted (in Shares) 2,052,134 2,047,641